NITISINONE
Generic: NITISINONE
Analog PharmaManufacturer
ORALRoute
NITISINONEActive Substance
2022-05-26Original Approval
NITISINONE is FDA application ANDA212390, sponsored by MEDUNIK. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
LIVER TRANSPLANT
32 reports
2
HEPATOCELLULAR CARCINOMA
22 reports
3
AMINO ACID LEVEL INCREASED
15 reports
4
TREATMENT NONCOMPLIANCE
14 reports
5
HEPATIC CIRRHOSIS
12 reports
6
HEPATIC FAILURE
12 reports
7
OFF LABEL USE
12 reports
8
DEATH
11 reports
9
ALPHA 1 FOETOPROTEIN INCREASED
10 reports
10
DRUG INEFFECTIVE
9 reports